I graduated from the University of Aberdeen in 2020 with a Psychology degree. I thoroughly enjoy working as a part of the EMERGE team and find working in research extremely interesting because due to the fast-paced and dynamic environment, I find myself always learning. I am delighted to be able to work with a strong team of clinical and research staff and provide my support for valuable research projects that I know are designed to benefit the care of patients. I am very grateful that due to becoming a member of EMERGE, I have gained a great insight to working within a clinical setting and this experience has allowed me to broaden my opportunities and explore promising career paths that make me excited for my future.
This trial is an open label two-arm randomised trial focused on identifying the best treatment for community acquired sepsis patients. We will be investigating the feasibility of delivering early intravenous fluid resuscitation by comparing 5% human albumin solution (HAS) to balanced crystalloid. Currently, balanced crystalloids are used as routine care and the first line therapy in the international sepsis guidelines, whereas HAS is the second line fluid therapy in septic shock. Although, studies are showing that HAS may have further potential benefits to patients with sepsis.